SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/27/24 Mannkind Corp. 10-K 12/31/23 123:18M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 3.75M 2: EX-4.3 Instrument Defining the Rights of Security Holders HTML 46K 5: EX-10.29 Material Contract HTML 525K 3: EX-10.4 Material Contract HTML 45K 4: EX-10.6 Material Contract HTML 48K 6: EX-23.1 Consent of Expert or Counsel HTML 34K 11: EX-97 Clawback Policy re: Recovery of Erroneously HTML 55K Awarded Compensation 7: EX-31.1 Certification -- §302 - SOA'02 HTML 39K 8: EX-31.2 Certification -- §302 - SOA'02 HTML 39K 9: EX-32.1 Certification -- §906 - SOA'02 HTML 37K 10: EX-32.2 Certification -- §906 - SOA'02 HTML 37K 13: R1 Document and Entity Information HTML 107K 14: R2 Consolidated Statements of Operations HTML 136K 15: R3 Consolidated Balance Sheets HTML 154K 16: R4 Consolidated Balance Sheets (Parenthetical) HTML 55K 17: R5 Consolidated Statements of Comprehensive Loss HTML 47K 18: R6 Consolidated Statements of Stockholders' Deficit HTML 134K 19: R7 Consolidated Statements of Cash Flows HTML 200K 20: R8 Description of Business HTML 44K 21: R9 Summary of Significant Accounting Policies HTML 155K 22: R10 Acquisition HTML 71K 23: R11 Investments HTML 123K 24: R12 Accounts Receivable HTML 77K 25: R13 Inventories HTML 51K 26: R14 Property and Equipment HTML 79K 27: R15 Goodwill and Other Intangible Asset HTML 58K 28: R16 Accrued Expenses and Other Current Liabilities HTML 80K 29: R17 Borrowings HTML 138K 30: R18 Collaboration, Licensing and Other Arrangements HTML 149K 31: R19 Fair Value of Financial Instruments HTML 108K 32: R20 Common and Preferred Stock HTML 60K 33: R21 Earnings Per Common Share ("Eps") HTML 82K 34: R22 Stock Award Plans HTML 151K 35: R23 Commitments and Contingencies HTML 199K 36: R24 Employee Benefit Plans HTML 43K 37: R25 Income Taxes HTML 229K 38: R26 Summary of Significant Accounting Policies HTML 232K (Policies) 39: R27 Summary of Significant Accounting Policies HTML 76K (Tables) 40: R28 Acquisition (Tables) HTML 66K 41: R29 Investments (Tables) HTML 118K 42: R30 Accounts Receivable (Tables) HTML 73K 43: R31 Inventories (Tables) HTML 49K 44: R32 Property and Equipment (Tables) HTML 72K 45: R33 Goodwill and Other Intangible Asset (Tables) HTML 54K 46: R34 Accrued Expenses and Other Current Liabilities HTML 81K (Tables) 47: R35 Borrowings (Tables) HTML 95K 48: R36 Collaboration, Licensing and Other Arrangements HTML 132K (Tables) 49: R37 Fair Value of Financial Instruments (Tables) HTML 101K 50: R38 Earnings Per Common Share ("Eps") (Tables) HTML 82K 51: R39 Stock Award Plans (Tables) HTML 127K 52: R40 Commitments and Contingencies (Tables) HTML 163K 53: R41 Income Taxes (Tables) HTML 221K 54: R42 Description of Business - Additional Information HTML 41K (Detail) 55: R43 Summary of Significant Accounting Policies - HTML 97K Additional Information (Detail) 56: R44 Summary of Significant Accounting Policies - HTML 39K Additional Information (Detail 1) 57: R45 Summary of Significant Accounting Policies - HTML 51K Summary of Revenue and Cost of Revenue and Goods Sold Generated From Product Sales, Services and Royalties (Detail) 58: R46 Acquisition - Additional Information (Detail) HTML 75K 59: R47 Acquisition - Schedule of Purchase Consideration HTML 45K (Detail) 60: R48 Acquisition - Schedule of Preliminary Amounts of HTML 65K Identifiable Assets Acquired and Liabilities Assumed (Details) 61: R49 Investments - Additional Information (Detail) HTML 86K 62: R50 Investments - Schedule of Contractual Maturities HTML 54K of Held to Maturity Investments (Detail) 63: R51 Investments - Schedule of Contractual Maturities HTML 45K of Held to Maturity Investments (Parenthetical) (Detail) 64: R52 Investments - Schedule of Fair Value of Cash HTML 82K Equivalents, Long and Short Term Investments (Detail) 65: R53 Schedule of Accounts Receivable, Net (Detail) HTML 50K 66: R54 Accounts Receivable - Additional Information HTML 56K (Detail) 67: R55 Schedule of Activities and Ending Reserve Balance HTML 41K (Detail) 68: R56 Inventories - Components of Inventory (Detail) HTML 44K 69: R57 Inventories - Additional Information (Detail) HTML 41K 70: R58 Property and Equipment, Net (Detail) HTML 71K 71: R59 Property and Equipment - Additional Information HTML 52K (Detail) 72: R60 Goodwill and Other Intangible Asset - Additional HTML 57K Information (Detail) 73: R61 Goodwill and Other Intangible Asset - Summary of HTML 45K Other Intangible Asset (Detail) 74: R62 Accrued Expenses and Other Current Liabilities HTML 57K (Detail) 75: R63 Accrued Expenses and Other Current Liabilities - HTML 43K Schedule of Provision for Discounts and Allowances for Commercial Product Sales (Detail) 76: R64 Borrowings - Summary of Carrying Amount of HTML 57K Borrowings (Detail) 77: R65 Borrowings - Schedule of Line of Credit Facility HTML 71K Debt and Key Terms (Detail) 78: R66 Borrowings - Schedule of Line of Credit Facility HTML 54K Debt and Key Terms (Parenthetical) (Detail) 79: R67 Borrowings - Schedule of Maturities of the HTML 54K Company's Borrowings (Detail) 80: R68 Borrowings - Senior Convertible Notes - Additional HTML 101K Information (Detail) 81: R69 Borrowings - MidCap Credit Facility - Additional HTML 127K Information (Detail) 82: R70 Borrowings - Mann Group Promissory Notes - HTML 106K Additional Information (Detail) 83: R71 Borrowings - Schedule of Amortization of Premium HTML 39K and Accretion of Debt Issuance Costs (Detail) 84: R72 Collaboration, Licensing and Other Arrangements - HTML 65K Schedule of Revenue from Collaborations and Services (Detail) 85: R73 Collaboration, Licensing and Other Arrangements - HTML 41K Schedule of Deferred Revenue Related to Revenue Recognized for Collaborations and Services (Detail) 86: R74 Collaboration, Licensing and Other Arrangements - HTML 50K Summary of UT Revenue (Detail) 87: R75 Collaboration, Licensing and Other Arrangements - HTML 122K Additional Information (Detail) 88: R76 Collaboration, Licensing and Other Arrangements - HTML 49K Revenue Allocation (Detail) 89: R77 Collaboration, Licensing and Other Arrangements - HTML 60K Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations (Detail) 90: R78 Collaboration, Licensing and Other Arrangements - HTML 51K Schedule of Revised Anticipated Cash Flows from Transactions Allocated Performance Obligations (Parenthetical) (Detail) 91: R79 Collaboration, Licensing and Other Arrangements - HTML 43K Additional Information (Detail 1) 92: R80 Fair Value of Financial Instruments - Fair Value HTML 59K of Financial Instruments (Detail) 93: R81 Fair Value of Financial Instruments - Fair Value HTML 79K of Financial Instruments (Parenthetical) (Detail) 94: R82 Common and Preferred Stock - Additional HTML 118K Information (Detail) 95: R83 Earnings Per Common Share ("EPS") - Components of HTML 62K Basic and Diluted EPS Computations (Detail) 96: R84 Earnings Per Common Share ("EPS") - Potential HTML 51K Dilutive Securities Outstanding that are Considered Antidilutive (Detail) 97: R85 Earnings Per Common Share ("EPS") - Potential HTML 38K Dilutive Securities Outstanding that are Considered Antidilutive (Parenthetical) (Detail) 98: R86 Stock Award Plans - Additional Information HTML 170K (Detail) 99: R87 Stock Award Plans - Stock Based Award Plans HTML 56K (Detail) 100: R88 Stock Award Plans - Stock Based Compensation HTML 57K Expense Recognized in Consolidated Statements of Operations by Category (Detail) 101: R89 Stock Award Plans - Summary of Stock Options HTML 76K Outstanding (Detail) 102: R90 Stock Award Plans - Summary of Restricted Stock HTML 58K Unit Activity (Detail) 103: R91 Commitments and Contingencies - Additional HTML 205K Information (Detail) 104: R92 Commitments and Contingencies - Schedule of HTML 39K Financing Liability Lease Term and Discount Rate (Detail) 105: R93 Commitments and Contingencies - Summary of HTML 36K Financing Liability Costs (Detail) 106: R94 Commitments and Contingencies - Schedule of HTML 52K Financing Liability Payments (Detail) 107: R95 Commitments and Contingencies - Remaining Purchase HTML 78K Commitments and Estimated Capacity Fee Liability Requirements (Detail) 108: R96 Commitments and Contingencies - Remaining Purchase HTML 36K Commitments and Estimated Capacity Fee Liability Requirements (Parenthetical) (Detail) 109: R97 Commitments and Contingencies - Schedule of Lease HTML 55K Term and Discount Rate (Detail) 110: R98 Commitments and Contingencies - Summary of Lease HTML 42K Information (Detail) 111: R99 Commitments and Contingencies - Schedule of Future HTML 54K Minimum Office And Vehicle Lease Payments (Detail) 112: R100 Employee Benefit Plans - Additional Information HTML 51K (Detail) 113: R101 Loss from Continuing Operations Before Provision HTML 42K for Income Taxes (Detail) 114: R102 Provision for Income Taxes (Detail) HTML 59K 115: R103 Components of Net Deferred Tax Assets (Detail) HTML 78K 116: R104 Effective Tax Rate (Detail) HTML 56K 117: R105 Income Taxes - Additional Information (Detail) HTML 68K 118: R106 Income Taxes - Summary of Positions for which HTML 39K Significant Change in Unrecognized Tax Benefits (Detail) 120: XML IDEA XML File -- Filing Summary XML 235K 123: XML XBRL Instance -- mnkd-20231231_htm XML 4.15M 119: EXCEL IDEA Workbook of Financial Report Info XLSX 281K 12: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 7.29M Linkbases Document -- mnkd-20231231 121: JSON XBRL Instance as JSON Data -- MetaLinks 791± 1.31M 122: ZIP XBRL Zipped Folder -- 0000950170-24-021423-xbrl Zip 884K
EX-23.1 |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-182457, 333-188790, 333-213366, 333-225428, 333-226648, and 333-242367, and 333-274176 on Form S-8, and Registration Statement No. 333-262981 on Form S-3 of our reports dated February 27, 2024, relating to the financial statements of MannKind Corporation and subsidiaries (“MannKind Corporation”) and the effectiveness of MannKind Corporation’s internal control over financial reporting appearing in this Annual Report on Form 10-K of MannKind Corporation for the year ended December 31, 2023.
Los Angeles, CA
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/27/24 | 8-K | ||
For Period end: | 12/31/23 | 4 | ||
List all Filings |